Empire Life Investments Inc. - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Empire Life Investments Inc. ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$757,000
-70.1%
106,225
+0.3%
0.07%
-64.1%
Q4 2019$2,528,000
-10.4%
105,856
+0.6%
0.19%
-18.6%
Q3 2019$2,822,000
+75.9%
105,212
+77.8%
0.24%
+81.5%
Q2 2019$1,604,000
-20.6%
59,159
+1.6%
0.13%
-23.1%
Q1 2019$2,020,000
-24.5%
58,219
-57.5%
0.17%
-29.6%
Q4 2018$2,675,000137,0520.24%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders